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Abstract 
The calciotropic hormone I a,25-dihydroxy-vitamin D 3 (1,25(OH)2D 3) has been shown to stimulate both rat and chick myoblast 
45Ca2+ uptake via modulation of dihydropyridine-sensitive L-type calcium channels through phosphorylation by the cAMP/protein 
kinase A pathway. We further investigated the involvement of protein kinases in 1,25(OH) 2Da-signal transduction on cultured myoblasts. 
The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) was found to rapidly stimulate myoblast 45Ca2+ uptake, 
mimicking 1,25(OH)2D 3.The effects of PMA were time- (1-5 min) and dose (50-100 nM)-dependent, were mimicked by 1,2-dioc- 
tanoylglycerol (DOG) and were specific, since the inactive analogue 4cz-phorbol was without effect. Analogously to the hormone, 
PMA-enhanced 45Ca2+ uptake was suppressed by the Ca2+-channel b ocker nifedipine (5 /xM). 1-(5-isoquinolynsulfonyl)-2-methyl- 
piperazine (H-7), a PKC inhibitor, and down-regulation fPKC by prolonged exposure to PMA (1 ~M, 24 h), abolished both PMA and 
hormone ffects on rat and chick cells. As in chick myoblasts, 1,25(OH)2D 3 activated PKC in rat myoblasts, with translocation ofactivity 
from the cytosol to the cell membrane. Treatment of myoblasts with PMA (100 nM) plus 1,25(OH)2D 3 (1 nM) greatly potentiated 45Ca2+ 
uptake than either agent alone. PMA also increased myoblast cAMP content. 
These results suggest the involvement of PKC in the mechanism by which 1,25(OH)eD 3 rapidly stimulates calcium uptake in both 
mammalian and avian myoblasts. 
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1. Introduction 
Vitamin D 3, through its hormonally active derivative 
1 a,25-dihydroxy-vitamin ])3 (1,25(OH) 2 D 3), regulates in- 
tracellular calcium homeostasis in classical (intestine, bone 
and kidney) and non-classical target issues, thus playing a 
role in regulating the specialized intracellular effects of 
calcium [1]. The hormone acts at target tissues via two 
different mechanisms: a genomic route, similarly to classi- 
cal steroids, through interaction with a nuclear eceptor [2] 
and a rapid membrane ffect which is independent of 
genome activation [3,4]. In skeletal and cardiac muscle, 
1,25(OH)2D 3 exerts an important modulatory function [5]. 
In vivo and in vitro studies have shown that the hormone 
increases 45Ca2+ uptake by both the genomic [6] and the 
non-genomic mechanism [7]. Recent observations in cul- 
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tured chick and rat myoblasts uggest he involvement of 
1,25(OH)2D 3 in the activation of voltage-dependent cal- 
cium-channels. Nifedipine, a calcium-channel antagonist, 
and extracellular EGTA completely abolished hormone-de- 
pendent increase of Ca x+ influx, while the stimulatory 
response was mimicked by the calcium-channel agonist 
Bay K8644 [8]. There is evidence indicating that in skele- 
tal muscle from vitamin D-deficient chicks [9], cultured 
cardiac muscle cells [10] and intestinal epithelial cells [11] 
1,25(OH)zD 3 affects enzyme systems involved in protein 
phosphorylation. In avian and mammalian myoblasts, it 
has recently been demonstrated that the mechanism of 
1,25(OH)2D3-enhanced Ca2+ entry involves modulation 
of dyhydropyridine-sensitive L-type Ca 2+ channels through 
phosphorylation by the cAMP/protein kinase A pathway 
[12]. In addition 1,25(OH)2D 3 regulates intracellular sig- 
nalling processes involving phospholipid metabolism [3]. 
In cultured myoblasts isolated from 12-day-old chick em- 
bryos, the hormone has been shown to stimulate the break- 
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down of membrane phosphoinositides l ading to the for- 
mation of the two second messengers inositol trisphos- 
phate (IP3) and diacylglycerol (DAG) with the subsequent 
activation of protein kinase C (PKC) [13]. 
In the present work we continue our search for the 
signalling systems activated by 1,25(OH)2D 3, examining 
the role of PKC in hormone-dependent calcium influx in 
cultured rat and embryonic hick myoblasts. 
2. Materials and methods 
presence or absence of the corresponding agonist. When 
nifedipine or H-7 were used, they were added to the 
cultures in the final 5 or 3 min of the equilibration period 
respectively, and throughout the assay. The assay was 
terminated after 5 min (or as indicated) of agonist expo- 
sure by aspirating the labelled medium and washing three 
times with ice-cold 140 mM NaC1, 10 mM Tris-HC1 (pH 
7.4), 1 mM LaC13. The cells were then dissolved in I N 
NaOH and aliquots were taken for radioactivity measure- 
ments, using Aquasol as scintillation fluid, and protein 
content determination by the method of Lowry et al. [16]. 
2.1. Materials 2.4. Down-regulation of protein kinase C 
1,25(OH) 2D 3 was kindly donated by Dr. M. Uskokovic 
(Hoffmann-La Roche, Nutley, NJ, USA). Phorbol 12-myri- 
state 13-acetate (PMA), 4c~-phorbol, 1,2-dioctanoylg- 
lycerol, 1,2-diolein, phosphatidylserine, l-(5-isoquinolyn- 
sulfonyl)-2-methyl-piperazine (H-7), histone H1 (Type III- 
S), PKC inhibitor from porcine heart (Type III), nifedipine, 
trypsin, Dulbecco's modified Eagle's medium, and fetal 
bovine serum were all purchased from Sigma Chemicals 
(St. Louis, MO, USA). 45CAC12 (2 mCi/ml) and [3/_ 
32p]ATP (3000 Ci/mmol) were from New England Nu- 
clear (Boston, MA, USA). Cyclic AMP radioassay kit was 
purchased from Diagnostics Products Corporation (DPA, 
Los Angeles, CA, USA). All other reagents used were of 
analytical grade. 
Chick and rat PKC-down-regulated myoblasts were pre- 
pared by treating the cultures with 1 /~M PMA for 24 h in 
culture medium as previously described [17]. Control cells 
were simultaneously processed by incubating cultures for 
the same time in the presence of vehicle (ethanol < 0.1%). 
Cells were then washed twice with KHG solution and once 
with KHG solution supplemented with 0.1% bovine serum 
albumin (BSA) in order to wash out either PMA or 
vehicle. Calcium uptake assays were then performed as 
described above. In order to check the efficiency of the 
down-regulation protocol, PKC activity in both control and 
down-regulated cells was determined by measuring PMA- 
induced phosphorylation of a PKC-specific peptide sub- 
strate [18]. 
2.2. Cell culture 2.5. Microsomal membrane preparation 
Myoblast cell cultures from the breast muscle of 12- 
day-old white leghorn chick embryos were prepared as 
described previously [13]. Rat myoblasts were isolated 
from neonate Wistar rats (4-5 days old) by a modification 
of a method previously described [14]. Briefly, thigh mus- 
cles were dissected, cleaned from connective and adipose 
tissues, and enzymatically dissociated by gently stirring in 
Earle's balanced saline solution containing 0.15% trypsin, 
at 37°C under constant flow of humidified 95% 02/5% 
CO 2 during 30 min. Dissociated cells were collected by 
centrifugation and suspended in Dulbecco's modified Ea- 
gle's medium supplemented with 10% inactivated fetal 
bovine serum [15]. Cells were seeded at appropriate den- 
sity in multiwell plates, and cultured at 37°C under humid- 
ified air (5% CO2). Cells were allowed to grow until 
70-80% confluence (4-5 days after plating) before use. 
Neonate rat myoblasts were grown to confluence in 
100-mm Petri dishes. After equilibration (15 min) in KHG 
solution, cells were exposed to either vehicle (ethanol < 
0.1%), 1,25(OH)2D 3 (1 nM) or PMA (50 nM) for 5 min. 
Medium was aspirated and cells homogenized with an 
Ultraturrax homogenizer (Jank and Kunkel, Staufen, Ger- 
many) in ice-cold lysing buffer containing 20 mM Tris-HCl 
(pH 7.4), 0.33 M sucrose, 1 mM EGTA, 0.5 mM phenyl- 
methylsulfonylfluoride (PMSF), 1 mM dithiothreitol 
(DTT), 40 /zg/ml leupeptin. The homogenate was cen- 
trifuged at 22 700 × g (20 min at 4°C) and the resultant 
suspension was centrifuged at 120000 X g (60 min at 
4°C). The obtained supernatant was stored (cytosolic frac- 
tion) and membrane pellets were suspended in homoge- 
nization buffer containing 1% Triton X-100. Both cytoso- 
lic and membrane fractions were tested for PKC activity. 
2.3. Determinat ion of45Ca 2 + uptake 2.6. Protein kinase C activity assay 
45Ca2+ uptake was performed essentially as previously 
described [8]. Briefly, culture medium was aspirated and 
the cells (70-80% confluence) were equilibrated 20 min in 
Krebs-Henseleit-0.2% glucose (KHG) solution. The assay 
was initiated by aspirating the medium and adding the 
same medium containing 45CAC12 (2 /xCi/ml) in the 
PKC activity was determined by a histone phosphoryla- 
tion assay [19]. Briefly, equal amounts of protein from 
both cytosolic and membrane fractions were incubated in 
20 mM Tris-HC1 (pH 7.4), 5 mM DTT, 10 mM 2-mer- 
captoethanol, 0.2 mM PMSF, 0.8 mg/ml BSA, 50 /xg 
histone H1 (type Ill-S), 10 mM MgC12 and 1 mM EGTA, 
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in the presence or absence of 1 mM CaC12, 38 /zg/ml 
phosphatidylserine (PS) and 45 /zg/ml 1,2-diolein (DO). ~ ao 
Reactions were started with addition of 50/zM [3,-32 P]ATP ~ 7o 
(1 /zCi/assay) and incubations proceeded for 5 min at ~ 6o 
30°C. The assay was stopped by protein precipitation with i "~ 
ice-cold 25% trichloroacetic a id (TCA); pellets were then v 4o 
washed four times with ice-cold 5% TCA, dissolved in 1 N 
NaOH and aliquots were taken for protein [16] and ra- so 
dioactivity measurements. PKC activity was calculated ~t] 2o 
from the difference in phosphorylation assayed with and ~ 10 
without Ca 2+, PS and DO. Enzyme activity was expressed 
as pmol of 32 Pi incorporaled/min per mg of protein. 
2.7. Determination of cyclic AMP 
Chick cell monolayers (70-80% confluence) were 
treated with vehicle (ethanol<0.1%), 1,25(OH)2D 3 (1 
nM), PMA (100 nM) or 1,25(OH)2D 3 plus PMA for 5 min 
at 37°C. The medium was removed and cells were immedi- 
ately frozen in liquid nitrogen. Samples were homogenized 
with an Ultraturrax homogenizer (Jank and Kunkel, 
Staufen, Germany) using 1 volume of ice-cold 6% perchlo- 
ric acid. The homogenate was centrifuged 15 min at 
22 700 × g, and the supernatant used for quantitation of 
cAMP by a competitive protein binding technique [20] 
using a commercially available kit. 
2.8. Statistical analysis 
The data were analyzed by using Student's t-test [21] 
and P < 0.05 was considered significant. Results are ex- 
pressed as means + S.D. of at least three separate xperi- 
ments. 
3. Results 
• CHICK 
o .  
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Fig. 1. Time course of the effects of PMA on rat and embryonic hick 
myoblast 45Ca2+ uptake. Rat and chick muscle cells were equilibrated at 
37°C in KHG (20 min) and then stimulated with PMA (50 nM) or vehicle 
(ethanol < 0.1%) for the indicated times in medium containing 45CAC12 
(2 /~Ci/ml). 45Ca2+ uptake was then measured as described in Section 
2. Results represent the average of three separate xperiments+S.D. 
* P < 0.001; * * P < 0.005. Calcium uptake control evels did not signif- 
icantly change with time (7.02 + 0.51 and 6.50 + 0.20 nmol Ca 2+/mg of 
protein for rat and chick cells respectively). 
increase of Ca 2~ influx [8] is related to membrane Ca 2÷- 
channel activity by regulation of PKC, which is involved 
in channel protein phosphorylation [22], the effect of cal- 
cium channel antagonists on PMA-dependent Ca 2 ÷ influx 
was evaluated. Table 1 shows that, similarly to the hor- 
mone [8], PMA effects were suppressed by nifedipine (5 
/xM), a dihydropyridine Ca2+-channel b ocker. When my- 
oblasts were simultaneously exposed to both 1,25(OH)zD 3
and PMA, a substantial potentiation of the effect of each 
agonist alone was observed (Fig. 3). However, preincuba- 
tion of cells with the PKC inhibitor H-7 (5 /~M) blocked 
both hormone and PMA actions. Additionally, down-regu- 
lation of PKC by long-term (24 h) pretreatment of cultures 
In the present work we examined the involvement of 
protein kinase C in the non-genomic mechanism by which 
1,25(OH)2D 3 rapidly stinmlates Ca 2+ uptake in cultured 
rat and embryonic hick myoblasts. The influence of phor- 
bol esters which are strong activators of PKC on myoblast 
45Ca2+ uptake were assayed. Fig. 1 shows that exposure of 
myoblasts to PMA rapidly increased 45 Ca 2 + uptake. Within 
1-5 min, the phorbol ester elevated Ca 2+ influx with 
maximal increases obtained at 5 min (65% and 40% above 
controls for rat and chick, respectively). The effects of 
PMA were dose-dependent (Fig. 2). Maximal stimulation 
of 45Ca2+ uptake was obtained at 50 nM (+84%) in rat 
and at 100 nM (+53%) in chick cells. As shown in Fig. 2, 
the inactive analogue 4a--phorbol (100 nM) was without 
effect, whereas the synthetic membrane permeable ana- 
logue of DAG, 1,2-dioclanoylglycerol (DOG, 50 /xM), 
also stimulated myoblast calcium uptake (+43% and 
+ 38% in rat and chick, respectively). 
To investigate whethe.r 1,25(OH)zD3-mediated rapid 
I1111PMA ( ,'50 nM ) ~4m'- PHOOBOL (I00 nM) 
- I  F)MA (I00 nM) ~'~ DOG (50 uM) 
i 8O RAT 
i .  
.= 
CHIClK 
Fig. 2. Stimulation of myoblast 45Ca2+ uptake by phorbol esters and 
synthetic diacylglycerol. Cultured rat and chick myoblasts were incubated 
in the presence or absence of PMA (50-100 nM), 4a-phorbol (100 nM) 
or DOG (50 /~M) for 5 min at 37°C. 45Ca2+ uptake was measured as 
described in Section 2. Results are the average +S.D. of three separate 
experiments. * P < 0.001; * * P < 0.005. 
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Table 1 
Nifedipine suppresses PMA-stimulated 45Ca2+ uptake in rat and chick 
myoblasts 
45Ca2+ uptake (nmol/mg protein) 
Rat Chick 
Control 7.2 4- 0.5 6.8 4- 0.3 
PMA 10.2 4-1.2 * * 11.5 4- 0.7 * 
Nifedipine 6.3 4- 0.2 6.9 _+ 0.5 
Nifedipine + PMA 7.3 +_ 0.4 * * * 7.5 _+ 0.6 
Cultured rat and chick myoblasts were equilibrated in KHG solution for 
20 min at 37°C, and then for 5 min in the same medium containing 
45CaC12 (2 /xCi/ml) in the absence or presence of PMA (rat: 50 nM, 
chick: 100 nM). When used, nifedipine (5 /zM) was added in the last 3 
rain of the equilibration period and throughout the treatment. 45Ca2+ 
uptake was then determined as described in Section 2. 
Results are the average of three separate xperiments + S.D. * P < 0.001; 
• * P <0.01; *** P<0.1.  
with 1 /zM PMA markedly reduced 1,25(OH)2D3-induced 
45Ca2+ uptake (Fig. 4). PMA-induced PKC activity was 
completely abolished in down-regulated cells, as evaluated 
by measuring PMA-dependent phosphorylation f a spe- 
cific PKC peptide substrate [18] (data not shown). 
Since adenylyl cyclase and its product cAMP mediate 
1,25(OH)2D3-dependent Ca 2+ uptake in myoblasts [12], it 
was therefore of interest o ascertain whether the phorbol 
ester affected myoblast levels of cAMP. Stimulation of 
chick myoblasts with PMA (Table 2) significantly elevated 
cellular cAMP ( + 53%). Further elevation of cAMP levels 
was observed when cells were simultaneously exposed to 
PMA and 1,25(OH)2D 3 (+210%). Down-regulation of 
"1 
I I x  
Fig. 3. Suppression of 1,25(OH)2D 3 and PMA-induced increase of 
45Ca2+ uptake in myoblasts by the PKC inhibitor H7. Cultured rat and 
chick myoblasts were equilibrated in KGH (20 min) and then treated for 
5 min with or without 1,25(OH)2D3 (1 nM), PMA (rat: 50 nM; chick: 
100 nM) or both. When used, H-7 (5 /zM) was added in the last 5 min of 
the equilibration period and throughout the treatment. 45Ca2+ uptake was 
then determined as described in Section 2. Results are the average of 
three separate xperiments4- S.D. * P < 0.001; * * P < 0.005. 
i .  
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Fig. 4. Down-regulation of PKC activity in myoblasts: its effect on 
1,25(OH) 2 D 3 and PMA-induced 45Ca2 + influx. Rat and chick myoblasts 
were incubated for 24 h at 37°C in culture medium containing 1 /.tM 
PMA (down-regulated cells) or vehicle (ethanol < 0.1%). After washing, 
cell monolayers were treated for 5 min with [me] 1,25(OH)2D3 (1 nM), 
[D] PMA (rat: 50 nM, chick: 100 nM) or vehicle. 45Ca2+ uptake was 
then measured as described in Section 2. Results are the average of three 
separate xperiments4- S.D. * P < 0.001; * * P < 0.005; * * * P < 0.01. 
Table 2 
cAMP content of chick myoblasts: effects of 1,25(OH)2D 3 and PMA 
cAMP (pmol.mg of protein) 
Down-regulated - + 
Control 2.42 _+ 0.20 2.73 _ 0.10 
PMA 3.70_+0.15 * 2.88+0.12 
1,25(OH) e D 3 4.81 5:0.10 * 4.13 + 0.40 * * 
1,25(OH) 2 D 3 + PMA 7.71 4- 0.15 * 4.28 4- 0.33 * 
Embryonic chick myoblasts (control and down-regulated) grown as 
monolayers (70-80% of confluence) were treated with or without (basal) 
1,25(OH)2D 3 (1 nM), PMA (100 nM) or both for 5 min at 37°C. 
Myoblasts were then processed for cAMP measurement as indicated in 
Section 2. 
Results are the average of three separate xperiments4-S.D. * P < 0.001; 
• * P < 0.005. 
Table 3 
Effects of PKA inhibitor (PK-I) on PMA and 1,25(OH)2Da-stimulated 
45Ca2+ uptake in myoblasts 
45Ca2 + Uptake 
(nmol/mg protein) 
Control 3.18 ___ 0.13 
1,25(OH) 2 D 3 5.26 + 0.30 * 
1,25(OH) 2 D 3 q- PK-I 3.42 + 0.11 
PMA 4.93+0.16 *
PMA+PK-I 3.27-1-0.15 
1,25(OH)2D 3+ PMA 8.62 + 0.28 * 
1,25(OH) 2 D 3 + PMA + PK-I 3.15 4- 0.25 
Cultured chick myoblasts were pretreated with the PKA inhibitor from 
porcine heart (35 /zg/ml) for 2 h. Cells were then equilibrated in KHG 
solution for 20 min at 37°C, and then for 5 min in the same medium 
containing 45CAC12 (2 /zCi/ml) in the absence or presence of 
1,25(OH)2D3 (1 nM), PMA (100 nM) or in combination. 45Ca2+ uptake 
was then determined as described in Section 2. 
Results are the average of two experiments performed in triplicate. 
+ S.D. * P < 0.001 
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Fig. 5. 1,25(OH)2D 3 stimulates membrane-bound PKC activity in rat 
myoblasts. Rat myoblasts were equilibrated in KHG solution and then 
exposed for 5 min at 37°C to either vehicle (ethanol < 0.1%), 
1,25(OH)2D3 (1 nM) or PMA (50 nM). Medium was then aspirated, cells 
homogenized in ice-cold lysing buffer and cytosolic and membrane 
fractions prepared as described in Section 2. PKC activity in each fraction 
was determined from the diferences in 32P i incorporation into histone 
(Type III-S) with or without CaCI 2, phosphatidylserine and 1,2-diolein. 
Results are the average of three separate xperiments + S.D. * P < 0.001. 
PKC completely abolished PMA effects and diminished 
hormone-dependent cAMP' formation. Furthermore, prein- 
cubation of cells with the PKA inhibitor PK-I (35 #g/ml )  
suppressed both, phorbol ester and hormone stimulation of 
45Ca uptake (Table 3). These results would explain, at least 
in part, the potentiation of Ca 2+ influx observed in re- 
sponse to simultaneous hormone and phorbol ester treat- 
ment. We previously reported that short exposure of chick 
myoblasts to 1,25(OH)2D 3 results in activation of mem- 
brane-bound PKC [13]. In order to test this possibility in 
mammalian cells, we evaluated the effect of the hormone 
on PKC activity in cultured rat myoblasts. Fig. 5 shows 
that in control, unstimulaled cells, 74% of myoblast en- 
zyme activity was in the cytosol and 26% was membrane- 
associated. PMA (50 nM, :5 min) markedly increased PKC 
activity in the membrane fraction (+90%) with a 2-fold 
stimulation of total (cytosol + membrane) enzyme activity 
(5.03 _+ 0.14 and 10.93 _+ 0.20 pmol 32p/min/mg protein 
for basal and PMA treated cells, respectively). Similarly, 5 
rain of treatment with 1.25(OH)2D 3 (1 nM) increased 
membrane-bound PKC aclivity (+ 54%), whereas it con- 
comitantly decreased in cytosol ( -  46%). Unlike the phor- 
bol ester, no significant change in total enzyme activity 
was observed between basal and hormone-stimulated c lls 
(5.11 + 0.10 pmol 32 P /min /mg protein). 
4. Discussion 
In the present study we have evaluated whether PKC is 
part of the mechanism by which the calciotropic hormone 
1,25(OH)2D 3 rapidly stimulates Ca 2+ influx in cultured 
myoblasts. We used tumor-promoting phorbol esters, which 
substitute for the naturally occurring DAG in stimulating 
PKC [23] and synthetic 1,2-dioctanoilglycerol, which 
rapidly penetrates into the cell membrane and mimics 
endogenous DAG [24], to elucidate whether activation of 
PKC is involved in the rapid effects of the hormone in 
cultured rat and embryonic hick myoblasts. PMA and 
DOG markedly increase 45Ca2+ uptake in both cellular 
species reproducing the rapid stimulation of Ca 2+ uptake 
elicited by 1,25(OH)2D 3 [8]. Similarly to the hormone [8], 
the acute rise in myoblast 45Ca2+ uptake evoked by PMA 
was suppressed by the Ca e +-channel antagonist nifedipine. 
This is in agreement with evidence indicating that PKC- 
mediated phosphorylation e hances calcium channel activ- 
ity [25]. That PKC activity is essential for 1,25(OH)2D 3 
action is supported by the fact that H7, an inhibitor of the 
enzyme [26], abolished the rise in 45Ca2+ uptake induced 
by either PMA or 1,25(OH)2D 3.Furthermore, down-regu- 
lation of PKC activity by long-term exposure to phorbol 
esters significantly diminished hormone stimulation of 
Ca 2+ influx. We previously reported that 1,25(OH)2D 3- 
stimulation of embryonic hick myoblasts causes intra- 
cellular DAG levels to rise, which activated PKC [13]. 
Similarly, in rat myoblasts, the hormone rapidly increased 
membrane-bound PKC activity with a concomitant de- 
crease in cytosol. Although these results suggest hat a 
similar mechanism of 1,25(OH)zD3-dependent PKC acti- 
vation might operate in rat myoblasts, the effects of the 
hormone on phospholipid metabolism in these cells remain 
to be investigated. Hormone translocation of PKC activity 
has been also reported in skeletal muscle from vitamin 
D3-deficient chicks [27] and rat colonic epithelium [28]. 
Recently, we have demonstrated that 1,25(OH)zD 3- 
stimulated influx of Ca 2+ into rat and embryonic hick 
myoblasts equentially requires inhibition of a pertussis- 
toxin sensitive G protein, accumulation of cAMP and 
activation of dihydropyridine-sensitive Ca 2+ channels 
through PKA-mediated phosphorylation events [12]. PKC 
activation can influence another second messenger system, 
namely cAMP generation [29,30]. Interactions between 
PKC and cAMP-generating systems are observed in a wide 
variety of cells. In some cells PKC activation results in 
potentiation [31,32] or inhibition [33,34] of cAMP forma- 
tion. In cultured myoblasts, the phorbol ester PMA, which 
directly activates PKC, elicited a rapid accumulation of 
cAMP and greatly potentiated cAMP formation induced by 
1,25(OH)2D 3. Opposite observations were made in chick 
heart cells and skeletal muscle from vitamin D3-deficient 
chicks, where PKC seems to negatively modulate hor- 
mone-induced 45Ca2+ uptake [27,35]. Several mechanisms 
have been proposed to explain the interactions between 
PKC and cAMP-generating systems. The stimulatory ef- 
fects of PKC on cAMP formation are thought o occur, in 
part, through phosphorylation f Ga i, the a subunit of the 
guanine-nucleotide binding protein involved in the inhibi- 
tion of adenylyl cyclase, thereby suppressing its inhibitory 
input to adenylyl cyclase [36]. Although activation of PKC 
162 G. Vazquez, A. Russo de Boland/Biochimica etBiophysiea Acta 1310 (1996) 157-162 
with pharmacological agents caused potentiation of 
1,25(OH)2D3-dependent Ca 2+ influx in myoblasts, the 
physiological significance of this effect is not clear. In 
most cells, more than one PKC isozyme is present. There- 
fore knowledge on the PKC isoforms involved in 
1,25(OH)2D 3 action as well as the identification of PKC 
targets within the adenylyl cyclase/cAMP/PKA cascade 
would contribute to clarify this matter. 
The present study as well as previous investigations [12] 
imply that PKC and PKA-dependent phosphorylation may 
be the primary mechanism underlying the rapid 
1,25(OH)iD3-dependent increase of Ca 2+ influx in both 
avian and mammalian cultured myoblasts. 
Acknowledgements 
This work was supported by grants from Consejo Na- 
cional de Investigaciones Cientificas y Tecnicas (CON- 
ICET) and Universidad Nacional del Sur. 
References 
[1] Walters, M. (1992) Endocrine Rev. 13, 719-764. 
[2] Minghetti, P,P. and Norman, A.W. (1988) FASEB J. 2, 3043-3053. 
[3] De Boland, A.R. and Nemere, I. (1992) J. Cell. Biochem. 49, 
32-36. 
[4] Nemere, I. and Norman, A.W. (1991) Mol, Cell. Endocrinol. 80, 
C165-C171. 
[5] Boland, R.L. (1986) Endocrinol. Rev. 7, 434-448. 
[6] De Boland, A.R. and Boland, R.L. (1987) Endocrinology 120, 
1858-1864. 
[7] De Boland, A.R. and Boland, R.L. (1994) Cell. Signal. 6, 717-724. 
[8] Vazquez, G. and De Boland, A.R. (1993) Biochem. Mol. Biol. Int. 
31 (4), 677-684. 
[9] Fernandez, L.M., Massheimer, V. and De Boland, A.R. (1990) 
Calcif. Tissue Int. 47, 314-352. 
[10] Selles, J., Bellido, T, and Boland, R.L. (1994) J. Mol. Cell. Cardiol. 
26, 1593-1599. 
[11] De Boland, A.R. and Norman, A.W. (1990) Endocrinology 127, 
39-45. 
[12] Vazquez, G., Boland, R.1. and De Boland, A.R. (1995) Biochim. 
Biophys. Acta (in press). 
[13] Morelli, S., De Boland, A.R. and Boland, R.L. (1993) Biochem. J. 
289, 675-679. 
[14] Yaffe, D. and Feldman, M. (1965) Dev. Biol. 11,300-317. 
[15] O'Neill, M.C. and Stockdale, F.E. (1972) J. Cell. Biol. 52, 52-65. 
[16] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) 
J. Biol. Chem. 193, 265-275. 
[17] Kawabe, J., Ohsaki, Y. and Onodera, S. (1992) Biochim. Biophys. 
Acta 1175, 81-87. 
[18] Alexander, D.R., Graves, J.D., Lucas, S.C., Cantrell, D.A. and 
Crumpton, M.J. (1990) Biochem. J. 268, 303-308. 
[19] Kikkawa, U., Minakuchi, R., Takai, Y. and Nishizuka, Y. (1983) 
Methods Enzymol. 90, 288-298. 
[20] Tovey, K.C., Oldham, K.G. and Whelan, J.A.M. (1974) Clin. Chim. 
Acta 56, 221-224. 
[21] Snedecor, G.W. and Cochran, W.G. (1967) Statistical Methods. The 
Iowa State University Press, Ames, IA. 
[22] McDonald, T.F., Pelzer, S., Trautwein, W. and Pelzer, D.G. (1994) 
Physiol. Rev. 74, 365-507. 
[23] Nishizuka, Y. (1984) Nature 308, 693-698. 
[24] Lapetina, E.G., Reep, B., Ganong, B.R. and Bell, R.M. (1985) J. 
Biol. Chem. 260, 1358-1361. 
[25] Catteral, W.A. (1988) Science 242, 50-61. 
[26] Hidaka, H., Inagakk M., Kawamoto, S. and Sasaki, Y. (1984) 
Biochemistry 23, 5036-5041, 
[27] Massheimer, V. and De Boland, A.R. (1992) Biochem. J. 281, 
349-352. 
[28] Wali, R.K., Baum, C.H., Strin, M.D. and Brasitus, T.A. (1990) J. 
Clin. Invest. 85, 1296-1303. 
[29] Houslay, M.D. (1991) Eur. J. Biochem. 195, 9-27. 
[30] Nishizuka, Y. (1986) Science 223, 305-312. 
[31] Hollingsworth, E.B., Ukena, D. and Daly, J.W. (1985) FEBS Lett. 
195, 131-134. 
[32] Bell, J.D. and Brunton, L.L. (1986) J. Biol. Chem. 261, 12036- 
12041. 
[33] Mukhopadhyay, A.K. and Schumacher, M. (1985) FEBS Lett. 186, 
56-60. 
[34] Rochette-Egly, C. and Castagna, M. (1979) FEBS Lett. 103, 38-42. 
[35] Marinissen, M.J., Selles, J. and Boland, R.L. (1994) Cell. Signal. 6, 
531-538. 
[36] Katada, T., Gilman, A.G., Watanabe, Y., Bauer, S. and Jakobs, K.H. 
(1985) Eur. J. Biochem. 151,431-437. 
